Dr Adam Januszewski路 @AdamJanuszewski 路 X路路 15 hours agoScore70
Body 路 original
馃毃 #ESMO26 SANOVO Ph3 馃嚚馃嚦 (China-only)
Impressive 1L savolitinib + osimertinib in EGFRm/MET-OE NSCLC:
馃搱 PFS 24.9 vs 13.8m (HR 0.56)
馃搱 OS 44.5 vs 34.9m (HR 0.48)
MET is a key target!
鉂揟arget MET in 1L or 2L? Amivantimab already targets MET. Efficacy similar. Tox will be key
2 views 路 0 likes 路 0 reposts 路 0 replies
Source: Dr Adam Januszewski 路 x.com